We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Next-Generation Sequencing Bioinformatics Tools and Resources Developed

By Labmedica staff writers
Posted on 27 Feb 2008
A new Software Development Community supports life scientists and independent software vendors to develop and commercialize innovative bioinformatics applications for next-generation genomic analysis platforms. More...


Applied Biosystems' (Foster City, CA, USA) Software Development Community has made formal agreements with Geospiza (Seattle, WA USA) and Genome Quest (Westborough, MA, USA) to develop bioinformatics tools for analysis and management of data generated by the SOLiD system, an extremely high throughput next-generation sequencing system. The new relationships should help scientists to realize the full potential of next-generation genomic analysis.

Through its Software Development Community, Applied Biosystems is the first manufacturer of next-generation instrument systems to make software development tools and resources widely available to the bioinformatics community. As a participant in the Software Development Community, Geospiza developed a software system to automate sequencing workflows for capillary electrophoresis (CE) instrumentation, and plans to expand its relationship with Applied Biosystems to include next-generation sequencing instruments. Processing both CE and SOLiD data through a single processing pipeline will enable researchers to integrate and visualize data sets from both technologies.

GenomeQuest has an integrated sequence information system, which, based on its database of reference sequences, can convert raw sequence data from the SOLiD system into insightful information. GenomeQuest's platform should also help SOLiD system users with sequence alignment and analysis, offering increased productivity, and enabling scalability as customers increasingly use next-generation genomic analysis platforms.

Applied Biosystems is a global leader in the development and commercialization of instrument-based systems, consumables, software, and services for the life science market, and is a market leader in the commercialization of DNA sequencing platforms. The SOLiD system, based on sequencing by oligonucleotide ligation and detection, is Applied Biosystems' next-generation system for ultra-high throughput genomic analysis. The SOLiD system utilizes a proprietary technology called stepwise ligation, which generates high quality data for applications, including whole genome sequencing, chromatin immunoprecipitation (ChIP), microbial and eukaryotic resequencing, digital karyotyping, medical sequencing, genotyping, gene expression, and small RNA discovery.

Geospiza combines deep life science and information technology (IT) expertise to provide highly scalable, fully integrated regulatory compliant informatics platforms for scaling their laboratory workflow, scientific data management, and analytics workflows. The company's customers are primarily molecular diagnostic laboratories, biotechnology and pharmaceutical companies, contract core labs, large research institutes and universities, involved in clinical DNA testing, manufacturing DNA based bio-therapeutics, delivering sequencing services to outside customers and basic life science research and discovery efforts.

GenomeQuest is a genomic information company providing applications and services to manage and mine the world's sequence data. The company's flagship product, GenomeQuest, is a web-based sequence information platform that enables sequence information specialists to exploit genomic data resources including next-generation sequencing tools and worldwide biologic sequence reference databases.


Related Links:
Applied Biosystems
Geospiza
Genome Quest

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
C-Reactive Protein Rapid Test
Afinion CRP
New
Myocardial Infarction Test
Finecare cTn I/NT-proBNP Rapid Quantitative Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.